Company Overview

Update
Status:
Acquired by MacroGenics
Founded:
1999
Founders:
Jennie P. Mather
Headquarters:
South San Francisco, CA
Funding:
$48.30M
Categories:
Biotechnology

Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.

Description

Update

Raven biotechnologies, Inc., a biotechnology company, focuses on the development of monoclonal antibody therapeutics for treating cancer. Its lead product candidate, RAV12, targets adenocarcinomas and used for the treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is based in South San Francisco, California. As of July 17, 2008, Raven Biotechnologies, Inc. operates as a subsidiary of MacroGenics, Inc.

Funding Rounds (1) - $48.30M

Update

Investors (12)

Update

Offices/Locations (1)

Update
  • Office

    One Corporate Drive

    South San Francisco, CA 94080

    USA